Skip to main content

Table 1 Experimental design and numbers of animals per group

From: Low-molecular-weight heparin reduces hyperoxia-augmented ventilator-induced lung injury via serine/threonine kinase-protein kinase B

 

Control + RA (WT)

Control + O2 (WT)

VT 30 ml/kg + RA (WT)

VT 30 ml/kg + O2 (WT)

VT 30 ml/kg + O2 with enoxaparin (WT)

VT 30 ml/kg + O2 (Akt+/-)

HMGB1, cell isolation

(8 hours of ventilation)

5

5

5

5

5

5

Phospho-Akt, HMGB1 mRNA (2, 4, 8 hours of ventilation)

5

5

5 × 3

5 × 3

5

5

MPO, lung edema

(8 hours of ventilation)

5

5

5

5

5

5

EBD assay (8 hours of ventilation)

5

5

5

5

5

5

MDA/GSH, IHC

(8 hours of ventilation)

5

5

5

5

5

5

  1. Akt = serine/threonine kinase/protein kinase B; Akt+/- = Akt deficient mice; Control = spontaneously breathing, nonventilated mice; EBD = Evans blue dye; GSH = total glutathione; HMGB1 = high-mobility group box-1; IHC = immunohistochemical stain; MDA = malondialdehyde; MPO = myeloperoxidase; O2 = mice with hyperoxia; RA = mice with room air; VT = tidal volume; WT: wild type.